MA44601A - Composition ophtalmique contenant de la pvp-i - Google Patents

Composition ophtalmique contenant de la pvp-i

Info

Publication number
MA44601A
MA44601A MA044601A MA44601A MA44601A MA 44601 A MA44601 A MA 44601A MA 044601 A MA044601 A MA 044601A MA 44601 A MA44601 A MA 44601A MA 44601 A MA44601 A MA 44601A
Authority
MA
Morocco
Prior art keywords
composition containing
ophthalmic composition
containing pvp
pvp
ophthalmic
Prior art date
Application number
MA044601A
Other languages
English (en)
Inventor
Danilo Aleo
Melina Cro
Sergio Mangiafico
Barbara MELILLI
Maria Grazia Saita
Original Assignee
Medivis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivis S R L filed Critical Medivis S R L
Publication of MA44601A publication Critical patent/MA44601A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79Polymers of vinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA044601A 2016-04-08 2017-02-17 Composition ophtalmique contenant de la pvp-i MA44601A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A002425A ITUA20162425A1 (it) 2016-04-08 2016-04-08 Composizione oftalmica che comprende PVP-I

Publications (1)

Publication Number Publication Date
MA44601A true MA44601A (fr) 2019-02-13

Family

ID=56555535

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044601A MA44601A (fr) 2016-04-08 2017-02-17 Composition ophtalmique contenant de la pvp-i

Country Status (14)

Country Link
US (1) US20200000714A1 (fr)
EP (1) EP3439631B1 (fr)
CN (1) CN108883064B (fr)
AU (1) AU2017247694B2 (fr)
CA (1) CA3019748C (fr)
CL (1) CL2018002861A1 (fr)
ES (1) ES2950498T3 (fr)
IT (1) ITUA20162425A1 (fr)
MA (1) MA44601A (fr)
MX (1) MX2018012311A (fr)
PL (1) PL3439631T3 (fr)
PT (1) PT3439631T (fr)
RU (1) RU2740910C2 (fr)
WO (1) WO2017175075A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108451903B (zh) * 2018-07-05 2019-03-22 广东腾骏动物药业股份有限公司 一种聚维酮碘溶液及其制备方法
US20210137887A1 (en) * 2018-07-24 2021-05-13 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use
US20210401878A1 (en) * 2019-08-18 2021-12-30 Iview Therapeutics, Inc. Stable Pharmaceutical Articles Containing Dilute Povidone Iodine Formulations
CN110559175A (zh) * 2019-08-27 2019-12-13 陈文龙 一种结膜囊消毒溶液及其使用方法和装置
WO2021156735A1 (fr) * 2020-02-03 2021-08-12 Medivis S.R.L. Formulations ophtalmiquesà base d'iodure de povidone à faible concentration stables dans des récipients en plastique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
GB0413954D0 (en) * 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
ES2719226T3 (es) * 2007-12-04 2019-07-09 Santen Sas Composiciones que comprenden profármacos de corticosteroides tales como palmitato de dexametasona para el tratamiento de trastornos oculares
ES2586283T3 (es) * 2008-05-28 2016-10-13 Novartis Ag Emulsiones autoconservadas
EP2291081B1 (fr) * 2008-06-12 2020-06-03 Foresight Biotherapeutics, Inc. La povidone iodée, nouveau conservateur innovant pour compositions ophtalmiques
IT1404931B1 (it) * 2010-06-11 2013-12-09 Medivis S R L Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液

Also Published As

Publication number Publication date
RU2018139074A3 (fr) 2020-06-30
ITUA20162425A1 (it) 2017-10-08
RU2018139074A (ru) 2020-05-12
ES2950498T3 (es) 2023-10-10
CA3019748A1 (fr) 2017-10-12
RU2740910C2 (ru) 2021-01-21
US20200000714A1 (en) 2020-01-02
CN108883064B (zh) 2022-09-16
MX2018012311A (es) 2019-05-22
CL2018002861A1 (es) 2019-02-22
CN108883064A (zh) 2018-11-23
BR112018070734A2 (pt) 2019-02-05
AU2017247694B2 (en) 2022-04-21
PL3439631T3 (pl) 2023-09-04
EP3439631B1 (fr) 2023-05-10
WO2017175075A1 (fr) 2017-10-12
EP3439631A1 (fr) 2019-02-13
CA3019748C (fr) 2024-01-09
PT3439631T (pt) 2023-07-28
AU2017247694A1 (en) 2018-10-25

Similar Documents

Publication Publication Date Title
MA42268A (fr) Compositions antimicrobiennes contenant des cannabinoïdes
MA54411A (fr) Compositions contenant de l'ibrutinib
MA41212A (fr) Composition de soin oral contenant des cannabinoïdes
BR112016030368A2 (pt) composição oftálmica
ES2904557T8 (es) Agentes inhibidores de irak4
BR112016023341A2 (pt) composição desinfetante de ação rápida
DK3416996T3 (da) Hærdelig sammensætning
DK3558278T3 (da) Flydende cannabinoidsammensætning
DK3532029T3 (da) Flydende farmaceutisk sammensætning
MA44601A (fr) Composition ophtalmique contenant de la pvp-i
DK3273947T3 (da) Sammensætning for øjensundhed
DK3278801T3 (da) Farmaceutisk sammensætning indeholdende mirabegron
BR112016018442A2 (pt) agentes antibacterianos
FR3020948B1 (fr) Composition antimicrobienne
IT201700117210A1 (it) Fungicida biologico
MA47516A (fr) Composition pharmaceutique
DK3393967T3 (da) Antimikrobiel polymersammensætning
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3216451T3 (da) Oftalmisk vandig sammensætning
DK3583934T3 (da) Biocidholdigt middel
DK3452093T3 (da) Ophthalmiske sammensætninger
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
FR3025106B1 (fr) Composition antimicrobienne
FR3025096B1 (fr) Composition gel/gel contenant un actif anti-transpirant
IT201700086257A1 (it) Soluzione di contrasto